Characteristics
|
Clonal groups, number of isolates (%)
|
P
a
|
---|
All isolates (n = 83)
|
O25b (n = 55)
|
O16 (n = 28)
|
O25b vs O16
|
---|
Source
|
Urine
|
55 (66.3%)
|
36 (65.5%)
|
19 (67.9%)
| |
Blood
|
12 (14.5%)
|
10 (18.2%)
|
2 (7.1%)
| |
Other
|
16 (19.3%)
|
9 (16.4%)
|
7 (25.0%)
| |
Antimicrobial resistance
|
ATM
|
30 (36.1%)
|
24 (43.6%)
|
6 (21.4%)
| |
CAZ
|
22 (26.5%)
|
16 (29.1%)
|
6 (21.4%)
| |
CTX
|
59 (71.1%)
|
41 (74.5%)
|
18 (64.3%)
| |
FEP
|
26 (31.3%)
|
22 (40.0%)
|
4 (14.3%)
|
0.024
|
TZP
|
1 (1.2%)
|
0
|
1 (3.6%)
| |
CIP
|
58 (69.9%)
|
49 (89.1%)
|
9 (32.1%)
|
< 0.001
|
LEV
|
58 (69.9%)
|
49 (89.1%)
|
9 (32.1%)
|
< 0.001
|
AMK
|
7 (8.4%)
|
4 (7.3%)
|
3 (10.7%)
| |
SXT
|
56 (67.5%)
|
36 (65.5%)
|
20 (71.4%)
| |
Adhesins
|
papAH
|
22 (26.5%)
|
19 (34.5%)
|
3 (10.7%)
|
0.034
|
papC
|
23 (27.7%)
|
21 (38.2%)
|
2 (7.1%)
|
0.004
|
papEF
|
22 (26.5%)
|
19 (34.5%)
|
3 (10.7%)
|
0.034
|
papG allele I
|
0
|
0
|
0
| |
papG allele II
|
21 (25.3%)
|
18 (32.7%)
|
3 (10.7%)
|
0.034
|
sfa/focDE
|
1 (1.2%)
|
1 (1.8%)
|
0
| |
focG
|
0
|
0
|
0
| |
afa/draBC
|
7 (8.4%)
|
2 (3.6%)
|
5 (17.9%)
|
0.040
|
fimH
|
82 (98.8%)
|
54 (98.2%)
|
28 (100%)
| |
gafD
|
0
|
0
|
0
| |
sfaS
|
7 (8.4%)
|
6 (10.9%)
|
1 (3.6%)
| |
Toxins
|
hlyA
|
14 (16.9%)
|
11 (20.0%)
|
3 (10.7%)
| |
cnf1
|
10 (12.0%)
|
8 (14.5%)
|
2 (7.1%)
| |
cdtB
|
0
|
0
|
0
| |
cvaC
|
3 (3.6%)
|
1 (1.8%)
|
2 (7.1%)
| |
Siderophores
|
fyuA
|
81 (97.6%)
|
53 (96.4%)
|
28 (100%)
| |
iutA
|
77 (92.8%)
|
52 (94.5%)
|
25 (89.3%)
| |
Capsules
|
kpsMTII
|
62 (74.7%)
|
43 (78.2%)
|
19 (67.9%)
| |
kpsMTIII
|
0
|
0
|
0
| |
kpsMT K1
|
10 (12.0%)
|
8 (14.5%)
|
2 (7.1%)
| |
kpsMT K5
|
47 (56.6%)
|
40 (72.7%)
|
7 (25.0%)
|
< 0.001
|
Miscellaneous
|
nfaE
|
0
|
0
|
0
| |
rfc
|
0
|
0
|
0
| |
malX
|
76 (91.6%)
|
51 (92.7%)
|
25 (89.3%)
| |
traT
|
73 (88.0%)
|
46 (83.6%)
|
27 (96.4%)
| |
Virulence scoresb
|
7 (3 to 11)
|
7 (3 to 11)
|
6 (4 to 10)
| |
-
a
P values, by either χ2 or Fisher’s exact test, are shown where P < 0.05
-
bmedian number of virulence factors (range)